Literature DB >> 12169762

Effects of angiotensins II and IV on blood pressure, renal function, and PAI-1 expression in the heart and kidney of the rat.

Christian T Abrahamsen1, Mark A Pullen, Christine G Schnackenberg, Eugene T Grygielko, Richard M Edwards, Nicholas J Laping, David P Brooks.   

Abstract

The role of angiotensin II (AII) and angiotensin IV (AIV) as inducers of PAI-1 expression during hypertension was studied in vivo. A 2-week infusion of AII (300 ng/kg/min) via an osmotic pump increased systolic blood pressure (171 +/- 2 vs. 138 +/- 6 mm Hg), urinary protein excretion (32 +/- 6 vs. 14 +/- 2 mg/day), and renal (2.2 +/- 0.5 vs. 1.0 +/- 0.1) and cardiac (1.8 +/- 0.3 vs. 1.0 +/- 0.1) gene expression of plasminogen activator inhibitor 1 (PAI-1). AIV infusion did not affect any of the above with the exception of PAI-1 gene expression which was increased in the left ventricles (1.7 +/- 0.3 vs. 1.0 +/- 0.1). AII-infused rats displayed a decreased creatinine clearance (538 +/- 75 vs. 898 +/- 96 ml/min) and hypertrophic left ventricles (0.275 +/- 0.006 vs. 0.220 +/- 0.011 g/100 g). Our results demonstrate that AII but not AIV infusion is associated with increased renal PAI-1 gene expression. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169762     DOI: 10.1159/000063252

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  6 in total

1.  AT1 receptor-activated signaling mediates angiotensin IV-induced renal cortical vasoconstriction in rats.

Authors:  Xiao C Li; Duncan J Campbell; Mitsuru Ohishi; Shao Yuan; Jia L Zhuo
Journal:  Am J Physiol Renal Physiol       Date:  2005-12-27

2.  Ets-1 upregulation mediates angiotensin II-related cardiac fibrosis.

Authors:  Guanghua Hao; Zhenhua Han; Zhe Meng; Jin Wei; Dengfeng Gao; Hong Zhang; Nanping Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts.

Authors:  G-H Hao; X-L Niu; D-F Gao; J Wei; N-P Wang
Journal:  Br J Pharmacol       Date:  2008-02-18       Impact factor: 8.739

4.  Effects of losartan and delapril on the fibrinolytic system in patients with mild to moderate hypertension.

Authors:  Salvatore Paterna; Vincenzo Di Garbo; Gino Avellone; Pietro Di Pasquale; Antonina Cacia; Antonio Tuttolomondo; Giuseppe Follone; Antonietta Cardinale; Tiziana Maniscalchi; Giuseppe Licata
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

Review 5.  Losartan chemistry and its effects via AT1 mechanisms in the kidney.

Authors:  Feichao Xu; Caiping Mao; Yujuan Liu; Lei Wu; Zhice Xu; Lubo Zhang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 6.  Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its Comorbidities.

Authors:  Prathibha Reddy Gajjala; Maryam Sanati; Joachim Jankowski
Journal:  Front Immunol       Date:  2015-07-08       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.